Results
|
121.
|
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study. [electronic resource] by
- Blackledge, G
- Verweij, J
- Fuchs, R
- Keizer, H J
- Somers, R
- Rankin, E
- Kerbrat, P
- van Oosterom, A
- Sylvester, R
- Thomas, D
Producer: 19900524
In:
European journal of cancer & clinical oncology vol. 25
Availability: No items available.
|
|
122.
|
|
|
123.
|
|
|
124.
|
|
|
125.
|
|
|
126.
|
|
|
127.
|
Phase I and pharmacokinetic study of flavone acetic acid. [electronic resource] by
- Kerr, D J
- Kaye, S B
- Cassidy, J
- Bradley, C
- Rankin, E M
- Adams, L
- Setanoians, A
- Young, T
- Forrest, G
- Soukop, M
Producer: 19880121
In:
Cancer research vol. 47
Availability: No items available.
|
|
128.
|
A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer. [electronic resource] by
- Rankin, E M
- Mill, L
- Kaye, S B
- Atkinson, R
- Cassidy, L
- Cordiner, J
- Cruickshank, D
- Davis, J
- Duncan, I D
- Fullerton, W
Producer: 19920324
In:
British journal of cancer vol. 65
Availability: No items available.
|
|
129.
|
|
|
130.
|
|
|
131.
|
|
|
132.
|
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial. [electronic resource] by
- Habeshaw, T
- Paul, J
- Jones, R
- Stallard, S
- Stewart, M
- Kaye, S B
- Soukop, M
- Symonds, R P
- Reed, N S
- Rankin, E M
Producer: 19910228
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 9
Availability: No items available.
|
|
133.
|
The myelotoxicity of carboplatin is influenced by the time of its administration. [electronic resource] by
- Kerr, D J
- Lewis, C
- O'Neil, B
- Lawson, N
- Blackie, R G
- Newell, D R
- Boxall, F
- Cox, J
- Rankin, E M
- Kaye, S B
Producer: 19900314
In:
Hematological oncology vol. 8
Availability: No items available.
|
|
134.
|
[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. [electronic resource] by
- Slotman, B J
- Faivre-Finn, C
- Kramer, G W P M
- Rankin, E
- Snee, M
- Hatton, M
- Postmus, P E
- Collette, L
- Musat, E
- Senan, S
Producer: 20080708
In:
Nederlands tijdschrift voor geneeskunde vol. 152
Availability: No items available.
|
|
135.
|
|
|
136.
|
Treatment of invasive thymoma with single-agent ifosfamide. [electronic resource] by
- Highley, M S
- Underhill, C R
- Parnis, F X
- Karapetis, C
- Rankin, E
- Dussek, J
- Bryant, B
- Rowland, C
- Hodson, N
- Hughes, J
- Harper, P G
Producer: 20000105
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
137.
|
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. [electronic resource] by
- Kaye, S B
- Lewis, C R
- Paul, J
- Duncan, I D
- Gordon, H K
- Kitchener, H C
- Cruickshank, D J
- Atkinson, R J
- Soukop, M
- Rankin, E M
Producer: 19920904
In:
Lancet (London, England) vol. 340
Availability: No items available.
|
|
138.
|
Report of a symposium on: diagnosis and treatment of cutaneous head and neck melanoma. [electronic resource] by
- Balm, A J
- Kroon, B B
- de Boer, J B
- Israels, S P
- Jonk, A
- Mooi, W J
- Neering, H
- Osterlind, A
- Rampen, F H
- Rankin, E M
Producer: 19940614
In:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 20
Availability: No items available.
|
|
139.
|
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. [electronic resource] by
- Coleman, R E
- Harper, P G
- Gallagher, C
- Osborne, R
- Rankin, E M
- Silverstone, A C
- Slevin, M L
- Souhami, R L
- Tobias, J S
- Trask, C W
Producer: 19870323
In:
Cancer chemotherapy and pharmacology vol. 18
Availability: No items available.
|
|
140.
|
The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis. [electronic resource] by
- Choy, E H
- Rankin, E C
- Kassimos, D
- Vetterlein, O
- Garyfallos, A
- Ravirajan, C T
- Sopwith, M
- Eastell, R
- Kingsley, G H
- Isenberg, D A
- Panayi, G S
Producer: 19991217
In:
The Journal of rheumatology vol. 26
Availability: No items available.
|